Dr. Christina Jenkins
Co-Founder & General Partner
Convergent Ventures
Speaker
Christina Jenkins, MD (“CJ”) is a venture investor, adviser, and board member who uses
technology and trusted relationships to improve health, at scale. Her expertise spans clinical
medicine, health systems, and health plans, and she applies her unique perspective to enable
value generation.
Dr. Jenkins is a Co-Founder and General Partner of Convergent Ventures and leads its health
and life sciences investing strategy. She focuses on Seed/A teams building AI-enabled
platforms and products from drug discovery through to human diagnosis, therapy, and
monitoring. She is a board member of Biotia and Tensor Bio.
She is an independent board member of PE-backed companies Help at Home and Medical Solutions. She is an advisory board member of
Independence Health Group (parent of Independence Blue Cross and AmeriHealth Caritas), and a National Advisor (subject matter
expert) to Manatt Health, advising C-suite leaders in provider and life sciences organizations. Dr. Jenkins is committed to advancing the
health of women, co-chairing an annual NYSE women’s health investor event and previously leading investments for Portfolia’s Femtech
fund.
Previously, Dr. Jenkins was the founding CEO of OneCity Health Services, a subsidiary of NYC Health + Hospitals, the nation’s largest
public hospital system. There, she led a $1.2B effort to redesign the care delivery continuum and accelerate value-based payment
readiness for 1M lives.
Dr. Jenkins earned her B.S. in Industrial Management at Purdue University and her M.D. from Northwestern University. She was a board-
certified Clinical Instructor of Medicine at Mount Sinai Medical Center in New York, where she also completed her residency. She is a
member of the Kauffman Fellows, a global leadership program in venture capital. Prior to medical school, Dr. Jenkins was an analyst
(FMP) for GE Healthcare.